Navigation Links
Study reveals inaccuracies in studies of cancer treatment
Date:4/20/2008

Certain biases may exist in observational studies that compare outcomes of different cancer therapies, making the results questionable. That is the conclusion of a new study published in the June 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The research suggests that observational studies should include more thorough information and should be better designed to minimize inaccuracies.

Clinical trials are considered the gold standard for demonstrating the effectiveness of new treatments for cancer, but observational studies, which do not involve randomization but where available data are nonetheless analyzed to make treatment comparisons, have also been used to provide information on how well patients respond to particular drugs. Many investigators perform these types of studies by analyzing data from the Surveillance, Epidemiology and End Results (SEER) Tumor Registry, a national population-based cancer registry that collects cancer-related information.

To determine the accuracy of observational studies on cancer treatments, Dr. Sharon H. Giordano of the University of Texas MD Anderson Cancer Center in Houston and her colleagues compared the effectiveness of different cancer therapies in terms of prolonging survival in patients, using data from the SEER registry. They presented several examples, including re-analyses of previously published data. In all cases, they came up with improbable results, indicating how easy it is to generate questionable results when conducting an observational study.

In their first analysis, the researchers looked at data on a hormone therapy called androgen deprivation in men with stage III prostate cancer. Randomized clinical trials have shown that androgen deprivation can improve survival in these patients. When the investigators analyzed data from the SEER registry of more than 5,000 men, they found that men treated with androgen deprivation actually had a higher risk of death from prostate cancer than men who did not receive the therapy.

Dr. Giordano and her team next re-analyzed data from a previously published study of more than 43,000 men with localized prostate cancer who were treated compared with men who were not treated. Like the original study, the researchers analysis revealed that men who were treated for prostate cancer experienced lower mortality rates. However, they also found that in many cases, the cause of death was due to something other than prostate cancer, such as diabetes or pneumonia.

Finally, the investigators re-analyzed data from a previously published study on the effects of fluorouracil-based chemotherapy for colon cancer. They came to the same conclusion as the original research studythat chemotherapy for node positive colon cancer is associated with improved survival. However, they found that the link between the treatment and survival was strongest for non-cancer deaths, which presumably are not related.

The authors attributed the improbable results found in their three analyses to selection biases when patients are treated. For example, selection bias occurs when patients with poorer prognoses are more likely to receive a more efficacious drug, or when patients with better underlying health are more likely to receive a more toxic treatment because they are more likely to tolerate it.

The authors concluded that their findings suggest that the results of observational studies of treatment outcomes should be viewed with caution. They recommended that analyses of observational data should at a minimum attempt to segregate patient outcomes into those that could possibly be due to the treatments vs. those that could not. Many observational studies on cancer treatments only report death rates from all causes and do not specify cancer-related deaths.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows
2. Choices Sap Your Stamina, Self Control: Study
3. Study finds patients overestimate cancer screening history
4. Parents stricter with older kids to set example: game theory study
5. Study finds 1 in 5 Iraq and Afghanistan veterans suffer from PTSD or major depression
6. RIT study: Sign language interpreters at high ergonomic risk
7. U-M study: Work hassles hamper sleep
8. Study provides new understanding of forces behind seasonal flu virus evolution
9. Seasonal Flu Outbreaks Start in Asia: Study
10. Study examines the effect of epilepsy on the aging
11. Study shows pine bark naturally reduces osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest Obamacare ... Bill Cassidy (R-LA) and Lindsey Graham ... that the medical device industry is in an odd ... tax, the 2.3% excise tax on medical device sales ... also want covered patients, increased visits and hospital customers ...
Breaking Medicine Technology: